https://www.acplgroupindia.in
91

7.5.1.1 General requirements The manufacturer shall plan and carry out production and serv...

View more

Design and development validation: Design and development validation shall be performed in...

View more

10.As provided in the rules, surrogate marker should be considered as an interim data poin...

View more

6. However, accelerated approval should be used for a drug that represent significant adva...

View more

After the NDA is accepted the various section of the application should undergo concurrent...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

View more

Note: Configuration management is a means by which identification and traceability can be...

View more

Obtaining a regulatory license often involves an application process, fees, background che...

View more

Subscribe for latest offers and updates.

we hate spam too